GSK PLC header image

GSK PLC

GSK

Equity

ISIN null / Valor 120042705

New York Stock Exchange, Inc (2026-03-04)
USD 56.83-0.42%

GSK PLC
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

GSK PLC is a global healthcare company specializing in pharmaceuticals and vaccines, dedicated to preventing and treating a wide range of diseases. The company operates through key therapeutic areas including respiratory, immunology and inflammation, oncology, as well as HIV and other infectious diseases. Notably, GSK majority-owns ViiV Healthcare, the sole company exclusively focused on HIV treatment and prevention, aiming to end the HIV epidemic. With a robust portfolio of over 20 marketed vaccines, GSK delivers more than one million vaccine doses daily, addressing infectious diseases across all age groups. The company's approach emphasizes early intervention and the use of advanced technologies to support healthcare systems and improve patient outcomes. GSK's commitment to responsible business practices underpins its strategy for long-term growth and trust-building with stakeholders.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

47.9%1Y
64.0%3Y
32.6%5Y

Performance

28.3%1Y
63.5%3Y
51.5%5Y

Volatility

Market cap

114399 M

Market cap (USD)

Daily traded volume (Shares)

3,815,317

Daily traded volume (Shares)

1 day high/low

34.04 / 33.56

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Bausch + Lomb Corporation
Bausch + Lomb Corporation Bausch + Lomb Corporation Valor: 116024614
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.39%USD 18.05
PACS Group Inc
PACS Group Inc PACS Group Inc Valor: 133777092
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.41%USD 36.35
Tenet Healthcare Corp
Tenet Healthcare Corp Tenet Healthcare Corp Valor: 19722583
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.79%USD 244.80
Conmed Corp
Conmed Corp Conmed Corp Valor: 920278
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.97%USD 42.99
National Healthcare Corp
National Healthcare Corp National Healthcare Corp Valor: 836282
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.36%USD 172.83
Dexcom Inc
Dexcom Inc Dexcom Inc Valor: 2107726
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.25%USD 72.90
Insulet Corp
Insulet Corp Insulet Corp Valor: 2941247
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.43%USD 242.89
Henry Schein Inc
Henry Schein Inc Henry Schein Inc Valor: 83527
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.46%USD 80.58
NovoCure Limited
NovoCure Limited NovoCure Limited Valor: 29570025
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.90%USD 13.42
Roivant Sciences Limited
Roivant Sciences Limited Roivant Sciences Limited Valor: 113331044
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.00%USD 29.52